Wiechmann Andrew C. 4
4 · MSCI Inc. · Filed Jan 28, 2026
Research Summary
AI-generated summary of this filing
MSCI CFO Andrew C. Wiechmann Receives 5,639 PSO Award
What Happened Andrew C. Wiechmann, Chief Financial Officer of MSCI Inc. (MSCI), received an award of performance stock options (PSOs) covering 5,639 shares. The Form 4 reports an acquisition/award (code A) of 5,639 derivative securities on January 26, 2026 at $0.00 (reported as a derivative grant, not a cash purchase). The PSOs were certified as having met their performance condition and are scheduled to vest on February 2, 2026, subject to continued service.
Key Details
- Transaction date: January 26, 2026 (Form 4 filed January 28, 2026 — timely filing).
- Reported amount: 5,639 performance stock options; reported price $0.00 (derivative award).
- Shares owned after transaction: Not specified in the filing.
- Footnote: PSOs were originally granted Feb 2, 2023, cover performance period Jan 1, 2023–Dec 31, 2025; performance condition was certified on Jan 26, 2026 and the PSOs vest on Feb 2, 2026 subject to continued service.
- Transaction type: Derivative award of PSOs (code A).
Context This is a compensation-related award (performance stock options) rather than an open-market buy or sell. The award reflects that the performance condition for the 2023–2025 period was met; the options are scheduled to vest in February 2026 and do not represent immediate share ownership or a sale. Such awards are common executive compensation and do not by themselves indicate an insider buying or selling shares.
Insider Transaction Report
- Award
Option to purchase common stock
[F1]2026-01-26+5,639→ 5,639 totalExercise: $554.52From: 2026-02-02Exp: 2033-02-02→ Common Stock (5,639 underlying)
Footnotes (1)
- [F1]Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 5,639 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.